Reuben, A., Spencer, C. N., Prieto, P. A., Gopalakrishnan, V., Reddy, S. M., Miller, J. P., . . . Little, L. D. (2017). Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma. NPJ genomic medicine, 2(1), N.PAG. https://doi.org/10.1038/s41525-017-0013-8
Chicago Style (17th ed.) CitationReuben, Alexandre, et al. "Genomic and Immune Heterogeneity Are Associated with Differential Responses to Therapy in Melanoma." NPJ Genomic Medicine 2, no. 1 (2017): N.PAG. https://doi.org/10.1038/s41525-017-0013-8.
MLA (9th ed.) CitationReuben, Alexandre, et al. "Genomic and Immune Heterogeneity Are Associated with Differential Responses to Therapy in Melanoma." NPJ Genomic Medicine, vol. 2, no. 1, 2017, p. N.PAG, https://doi.org/10.1038/s41525-017-0013-8.